Metabolic abnormalities in growth hormone deficiency

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Metabolic Health

Background:

• Growth hormone (GH) plays a role in cardiovascular function, bone turnover, and mineral deposition.
• Growth hormone deficiency (GHD) is associated with increased cardiovascular morbidity and mortality in both pediatric and adult populations.
• GHD presents with metabolic abnormalities including dyslipidemia, increased adiposity, insulin resistance, and impaired cardiac function.

Purpose of the Study:

• To review the impact of GHD on cardiovascular health and bone metabolism.
• To summarize the cardiovascular and metabolic consequences of GHD.
• To discuss the therapeutic benefits of GH treatment on these parameters.

Main Methods:

• Literature review of studies investigating GHD and cardiovascular disease.
• Analysis of metabolic and cardiovascular risk factors in GHD patients.
• Evaluation of the effects of short and long-term GH treatment.

Main Results:

• GHD is associated with elevated lipids, increased body fat, premature atherosclerosis, and impaired cardiac performance.
• GH deficiency contributes to decreased fibrinolytic activity and increased peripheral insulin resistance.
• GH therapy has demonstrated beneficial effects on several cardiovascular and metabolic parameters in GHD patients.

Conclusions:

• GHD significantly increases cardiovascular risk and affects bone health.
• GH treatment can ameliorate many of the adverse cardiovascular and metabolic sequelae of GHD.
• Further investigation into metabolic changes in pediatric GHD is warranted.